Currently Funded Research

Dr Neil Rajan,
Newcastle University, UK       

Delineating the Cutaneous Tumour Microenvironment in Birt-Hogg-Dubé Syndrome                                                                                    

Learn more about Neil’s research project here.

Dr Arjan Houweling,
Amsterdam UMC, The Netherlands

Improving Care for Birt-Hogg-Dubé Syndrome Patients: Clinical and Genetic Analysis of a Unique Cohort                                    

Learn more about Arjan’s research project here.

Professor Stefan Marciniak,
University of Cambridge, UK

Determining the Prevalence of Pathogenic FLCN Variants from Large Genomic Registries                          

Learn more about Stefan’s research project here.

Professor Masaya Baba,
Kumamoto University, Japan

CRISPR/Cas9 Mediated Unbiased Genome Wide Screening to Target both Tumour Cell Autonomous and Tumour Microenvironmental Factors in FLCN Deficient RCC Cells

Learn more about Masaya’s research project here.

Dr Fulya Taylan,
Karolinska Institute, Sweden

Investigating Molecular Mechanisms of an Autosomal Recessive FLCN-related Disorder Resembling Biallelic FNIP1 Disorder

Learn more about Fulya’s research project here.

Dr Wolfgang Paster,
Children’s Cancer Research Institute, Vienna, Austria

The Immunopeptidome of Paediatric High-Grade Osteosarcoma                                                                                                                    

Learn more about Wolfgang’s research project here.

Professor Nancy DeMore,
Medical University of South Carolina, USA

Combination Therapy with a Humanized Monoclonal Antibody to Secreted Frizzled Related Protein 2 for Metastatic Osteosarcoma

Learn more about Nancy’s research project here.

Professor Graham Cook and Dr Fiona Errington-Mais,
University of Leeds, UK

Oncolytic Virus-based Activation of Natural Killer Cells for the Immunotherapy of Osteosarcoma                                                     

Learn more about Graham and Fiona’s research project here.